Supramolecular prodrug inspiried by the <i>Rhizoma Coptidis</i>-<i>Fructus Mume</i> herbal pair alleviated inflammatory diseases by inhibiting pyroptosis

Wenhui Qian; Bei Zhang; Ming Gao; Yuting Wang; Jiachen Shen; Dongbing Liang; Chao Wang; Wei Wei; Xing Pan; Qiuying Yan; Dongdong Sun; Dong Zhu; Haibo Cheng

doi:10.1016/j.jpha.2024.101056

Volume 15 Issue 2

Feb. 2025

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2025 > 15(2): 101056

Wenhui Qian, Bei Zhang, Ming Gao, Yuting Wang, Jiachen Shen, Dongbing Liang, Chao Wang, Wei Wei, Xing Pan, Qiuying Yan, Dongdong Sun, Dong Zhu, Haibo Cheng. Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis[J]. Journal of Pharmaceutical Analysis, 2025, 15(2): 101056. doi: 10.1016/j.jpha.2024.101056

Citation:

Wenhui Qian, Bei Zhang, Ming Gao, Yuting Wang, Jiachen Shen, Dongbing Liang, Chao Wang, Wei Wei, Xing Pan, Qiuying Yan, Dongdong Sun, Dong Zhu, Haibo Cheng. Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis[J]. Journal of Pharmaceutical Analysis, 2025, 15(2): 101056. doi: 10.1016/j.jpha.2024.101056

Citation:

Wenhui Qian, Bei Zhang, Ming Gao, Yuting Wang, Jiachen Shen, Dongbing Liang, Chao Wang, Wei Wei, Xing Pan, Qiuying Yan, Dongdong Sun, Dong Zhu, Haibo Cheng. Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis[J]. Journal of Pharmaceutical Analysis, 2025, 15(2): 101056. doi: 10.1016/j.jpha.2024.101056

PDF( 5616 KB)

Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis

doi: 10.1016/j.jpha.2024.101056

a. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China;
b. Department of Pharmacy, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China;
c. Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, 210023, China

Funds:

The work was financial supported by the Project of National Natural Science Foundation of China (Grant No.: 82274219 and 81930117). We also thank the Key Project of Traditional Chinese Medicine Technology Development Plan of Jiangsu Province, China (Grant No.: ZD202201) and Jiangsu Province Postgraduate Scientific Research Practice and Innovation Plan Project, China (Grant Nos.: KYCX21_1735 and SJCX21_0679).

Received Date: Mar. 25, 2024
Accepted Date: Jul. 28, 2024
Rev Recd Date: Jul. 25, 2024
Publish Date: Jul. 31, 2024

Abstract

Abstract

Sustained inflammatory responses are closely related to various severe diseases, and inhibiting the excessive activation of inflammasomes and pyroptosis has significant implications for clinical treatment. Natural products have garnered considerable concern for the treatment of inflammation. Huanglian-Wumei decoction (HLWMD) is a classic prescription used for treating inflammatory diseases, but the necessity of their combination and the exact underlying anti-inflammatory mechanism have not yet been elucidated. Inspired by the supramolecular self-assembly strategy and natural drug compatibility theory, we successfully obtained berberine (BBR)-chlorogenic acid (CGA) supramolecular (BCS), which is an herbal pair from HLWMD. Using a series of characterization methods, we confirmed the self-assembly mechanism of BCS. BBR and CGA were self-assembled and stacked into amphiphilic spherical supramolecules in a 2:1 molar ratio, driven by electrostatic interactions, hydrophobic interactions, and π-π stacking; the hydrophilic fragments of CGA were outside, and the hydrophobic fragments of BBR were inside. This stacking pattern significantly improved the anti-inflammatory performance of BCS compared with that of single free molecules. Compared with free molecules, BCS significantly attenuated the release of multiple inflammatory mediators and lipopolysaccharide (LPS)-induced pyroptosis. Its anti-inflammatory mechanism is closely related to the inhibition of intracellular nuclear factor-kappaB (NF-κB) p65 phosphorylation and the noncanonical pyroptosis signalling pathway mediated by caspase-11.
- Self-assembly,
- Anti-inflammation,
- Supramolecular,
- Pyroptosis,
- Traditional Chinese medicine

FullText(HTML)

References(46)

References

[1]	H.-C. Ku, S.-Y. Lee, S.-S. Lee, et al., Thaliporphine, an alkaloid from Neolitsea konishii, exerts antioxidant, anti-inflammatory, and anti-apoptotic responses in guinea pig during cardiovascular collapse in inflammatory disease, J. Funct. Foods 26 (2016) 57-64.
[2]	C.-J. Liou, S. Wu, L. Chen, et al., Acacetin from traditionally used Saussurea involucrata Kar. et kir. suppressed adipogenesis in 3T3-L1 adipocytes and attenuated lipid accumulation in obese mice, Front. Pharmacol. 8 (2017), 589.
[3]	D. Hirayama, T. Iida, H. Nakase, The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis, Int. J. Mol. Sci. 19 (2017), 92.
[4]	M. Wu, J. Lu, Autophagy and macrophage functions: Inflammatory response and phagocytosis, Cells 9 (2019), 70.
[5]	M. Biasizzo, N. Kopitar-Jerala, Interplay between NLRP3 inflammasome and autophagy, Front. Immunol. 11 (2020), 591803.
[6]	E.-K. Jo, J.K. Kim, D.-M. Shin, et al., Molecular mechanisms regulating NLRP3 inflammasome activation, Cell. Mol. Immunol. 13 (2016) 148-159.
[7]	M. Groslambert, B.F. Py, Spotlight on the NLRP3 inflammasome pathway, J. Inflamm. Res. 11 (2018) 359-374.
[8]	S. Paik, J.K. Kim, P. Silwal, et al., An update on the regulatory mechanisms of NLRP3 inflammasome activation, Cell. Mol. Immunol. 18 (2021) 1141-1160.
[9]	Z. Wang, W. Hu, C. Lu, et al., Targeting NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome in cardiovascular disorders, Arterioscler. Thromb. Vasc. Biol. 38 (2018) 2765-2779.
[10]	R. Fusco, R. Siracusa, T. Genovese, et al., Focus on the role of NLRP3 inflammasome in diseases, Int. J. Mol. Sci. 21 (2020), 4223.
[11]	S. Wang, Y. Yuan, N. Chen, et al., The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinsoease, Int. Immunopharmacol. 67 (2019) 458-464.
[12]	P. Yu, X. Zhang, N. Liu, et al., Pyroptosis: Mechanisms and diseases, Signal Transduct. Target. Ther. 6 (2021), 128.
[13]	X. Huang, Y. Feng, G. Xiong, et al., Caspase-11, a specific sensor for intracellular lipopolysaccharide recognition, mediates the non-canonical inflammatory pathway of pyroptosis, Cell Biosci. 9 (2019), 31.
[14]	L. Wang, W. Wei, X. Zhang, et al., An integrated proteomics and bioinformatics approach reveals the anti-inflammatory mechanism of carnosic acid, Front. Pharmacol. 9 (2018), 370.
[15]	M. Mosihuzzaman, Herbal medicine in healthcare - An overview, Nat. Prod. Commun. 7 (2012) 807-812.
[16]	X. Zhou, S.W. Seto, D. Chang, et al., Synergistic effects of Chinese herbal medicine: A comprehensive review of methodology and current research, Front. Pharmacol. 7 (2016), 201.
[17]	J. Wang, A. Sasse, H. Sheridan, Traditional Chinese medicine: From aqueous extracts to therapeutic formulae. Plant Extracts, IntechOpen Limited, London, 2019.
[18]	T.-P. Fan, Y. Zhu, C. Leon, et al., Traditional Chinese medicine herbal drugs: From heritage to future developments. The Science and Regulations of Naturally Derived Complex Drugs. Springer Cham, 2019, pp. 59-77.
[19]	S. Wang, Y. Hu, W. Tan, et al., Compatibility art of traditional Chinese medicine: From the perspective of herb pairs, J. Ethnopharmacol. 143 (2012) 412-423.
[20]	X.H. Ma, C.J. Zheng, L.Y. Han, et al., Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives, Drug Discov. Today 14 (2009) 579-588.
[21]	X. Wu, H. Chen, X. Gao, et al., Natural herbal remedy Wumei decoction ameliorates intestinal mucosal inflammation by inhibiting Th1/Th17 cell differentiation and maintaining microbial homeostasis, Inflamm Bowel Dis. 28 (2022) 1061-1071.
[22]	Y. Yang, G. Xiao, P. Cheng, et al., Protective application of Chinese herbal compounds and formulae in intestinal inflammation in humans and animals, Molecules 28 (2023), 6811.
[23]	S. Yan, P. Wang, H. Wei, et al., Treatment of ulcerative colitis with Wu-Mei-Wan by inhibiting intestinal inflammatory response and repairing damaged intestinal mucosa, Phytomedicine 105 (2022), 154362.
[24]	F. Meng, Z. Wu, Z. Yin, et al., Coptidis rhizoma and its main bioactive components: Recent advances in chemical investigation, quality evaluation and pharmacological activity, Chin. Med. 13 (2018), 13.
[25]	X. Shang, H. Pan, M. Li, et al., Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine, J. Ethnopharmacol. 138 (2011) 1-21.
[26]	C. Bailly, Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot), J. Ethnopharmacol. 246 (2020), 112215.
[27]	F. Wu, Q. Shao, Z. Cheng, et al., Traditional herbal formula Wu-Mei-Wan alleviates TNBS-induced colitis in mice by inhibiting necroptosis through increasing RIPK3 O-GlcNAcylation, Chin. Med. 16 (2021), 78.
[28]	S. Zhang, Discovery and design of self-assembling peptides, Interface Focus 7 (2017), 20170028.
[29]	A.R. Hirst, B. Escuder, J.F. Miravet, et al., High-tech applications of self-assembling supramolecular nanostructured gel-phase materials: From regenerative medicine to electronic devices, Angew. Chem. Int. Ed. Engl. 47 (2008) 8002-8018.
[30]	S. Li, T. Xiao, C. Lin, et al., Advanced supramolecular polymers constructed by orthogonal self-assembly, Chem. Soc. Rev. 41 (2012) 5950-5968.
[31]	J.M. Zayed, N. Nouvel, U. Rauwald, et al., Chemical complexity - Supramolecular self-assembly of synthetic and biological building blocks in water, Chem. Soc. Rev. 39 (2010) 2806-2816.
[32]	Z. Wang, J. Lu, Z. Yuan, et al., Natural carrier-free binary small molecule self assembled hydrogel synergize antibacterial effects and promotewound healing by inhibiting virulence factors and alleviating the inflammatory response, Small 19 (2023), e2205528.
[33]	P. Liang, T. Bi, Y. Zhou, et al., Insights into the mechanism of supramolecular self-assembly in the Astragalus membranaceus-Angelica sinensis codecoction, ACS Appl. Mater. Interfaces. 15 (2023), 47939-47954.
[34]	R. Huang, B.L.T. Lau, Biomolecule-nanoparticle interactions: Elucidation of the thermodynamics by isothermal titration calorimetry, Biochim. Biophys. Acta 1860 (2016) 945-956.
[35]	M. Kabiri, L.D. Unsworth, Application of isothermal titration calorimetry for characterizing thermodynamic parameters of biomolecular interactions: Peptide self-assembly and protein adsorption case studies, Biomacromolecules 15 (2014) 3463-3473.
[36]	K. Zou, Z. Li, Y. Zhang, et al., Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system, Acta Pharmacol. Sin. 38 (2017) 157-167.
[37]	B. Wang, A. Deng, Z. Li, et al., Syntheses and structure-activity relationships in growth inhibition activity against human cancer cell lines of 12 substituted berberine derivatives, Molecules 25 (2020), 1871.
[38]	J. Checa, J.M. Aran, Reactive oxygen species: Drivers of physiological and pathological processes, J. Inflamm. Res. 13 (2020) 1057-1073.
[39]	X. Wang, V. Antony, Y. Wang, et al., Pattern recognition receptor-mediated inflammation in diabetic vascular complications, Med. Res. Rev. 40 (2020) 2466-2484.
[40]	H. Duez, B. Pourcet, Nuclear receptors in the control of the NLRP3 inflammasome pathway, Front. Endocrinol. 12 (2021), 630536.
[41]	A. Zamyatina, H. Heine, Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4/11 mediated inflammatory pathways, Front. Immunol. 11 (2020), 585146.
[42]	Y.-S. Yi, Caspase-11 non-canonical inflammasome: A critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses, Immunology 152 (2017) 207-217.
[43]	A. Abu Khweek, A.O. Amer, Pyroptotic and non-pyroptotic effector functions of caspase-11, Immunol. Rev. 297 (2020) 39-52.
[44]	X. Liu, Z. Zhang, J. Ruan, et al., Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores, Nature 535 (2016) 153-158.
[45]	X. Liu, J. Lieberman, A mechanistic understanding of pyroptosis: The fiery death triggered by invasive infection, Adv. Immunol. 135 (2017) 81-117.
[46]	L. Liu, Y. Wang, X. Guo, et al., A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy, Small 16 (2020), e2003543.